- Filed
- May 8, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Apr 30, 2025 | 73.45M sh |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $2.83B |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $2.86B |
| Short Term Debt | Q1 2025 · Mar 31, 2025 | $81M |
| Short Term Debt | Q1 2025 · Dec 31, 2024 | $81M |
| Stockholders Equity | Q1 2025 · Mar 31, 2025 | $275M |
| Stockholders Equity | Q1 2025 · Dec 31, 2024 | $260M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $1.89B |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $1.7B |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $5.46B |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $5.29B |
| Current Assets | Q1 2025 · Mar 31, 2025 | $1.94B |
| Current Assets | Q1 2025 · Dec 31, 2024 | $1.77B |
| Total Assets | Q1 2025 · Mar 31, 2025 | $5.74B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $5.55B |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $419M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2024 | $343M |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 71.6M sh |
| Capex | Q1 2025 · Mar 31, 2024 | $24M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $148M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | −$0.11 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | −$0.11 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $132M |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $17M |
| Net Income | Q1 2025 · Mar 31, 2024 | −$8M |
| Operating Income | Q1 2025 · Mar 31, 2024 | $72M |
| Revenue | Q1 2025 · Mar 31, 2024 | $1.05B |